Anti-Mouse CD4 (Clone YTS191) – Purified in vivo PLATINUM™ Functional Grade
Anti-Mouse CD4 (Clone YTS191) – Purified in vivo PLATINUM™ Functional Grade
Product No.: C3210
Clone YTS191 Target CD4 Formats AvailableView All Product Type Monoclonal Antibody Isotype Rat IgG2b κ Applications Depletion , FC , IHC FF , in vivo , WB |
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Rat Recommended Isotype Controls Recommended Dilution Buffer Immunogen Unknown Product Concentration ≥ 5.0 mg/ml Endotoxin Level <0.5 EU/mg as determined by the LAL method Purity ≥98% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Pathogen Testing To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM™ antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day 2-8°C RRIDAB_2893557 Applications and Recommended Usage? Quality Tested by Leinco FC Additional Applications Reported In Literature ? Depletion IHC (Frozen) Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone YTS191 recognizes an epitope on mouse CD4.
Background CD4 antibody, clone YTS191, recognizes CD4, a 58 kDa type I transmembrane glycoprotein of the Ig superfamily. CD4 is expressed by the majority of thymocytes, MHC class II-restricted T cells (helper T cells and immunosuppressive regulatory T cells), and subsets of natural killer T (NKT) cells, dendritic cells (DCs) and macrophages1-3. On T cells, CD4 is a co-receptor of the T cell receptor (TCR) and interacts with major histocompatibility complex (MHC) II molecules on antigen-presenting cells (APCs). CD4 contributes to T cell development and selection and enhances TCR-dependent signaling by up to 100-fold through the accumulation of Lck4-6. CD4 also contributes to the activation of NKT, macrophages, and DCs7,8.
Antigen Distribution CD4 is expressed on most thymocytes, MHC class II-restricted T cells, a subset of NKT cells, and subsets of dendritic cells and macrophages.
Research Area Immunology Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Clone YTS191 is primarily used in in vivo mouse studies to selectively deplete CD4+ T cells, which are critical components of the immune system, including helper T cells and regulatory T cells. Researchers administer this monoclonal antibody to mice, where it binds to the CD4 glycoprotein on target cells and facilitates their removal, allowing investigation of the role of CD4+ T cells in specific immune processes and disease models. Key uses in in vivo mouse studies include:
Important experimental details:
In summary, YTS191 is a validated tool for the depletion and functional analysis of CD4+ cells in vivo, enabling the study of their roles in the mouse immune system and various disease states. The recommended storage temperature for sterile packaged clone YTS191 (anti-mouse CD4 antibody) is -20°C to -70°C for long-term storage and 2-8°C for up to one month.
Avoid repeated freezing and thawing, and do not use frost-free freezers, as these conditions can denature the antibody and reduce functionality. YTS191 is a monoclonal antibody specific for mouse CD4, commonly used for CD4+ T cell depletion and functional studies in vivo. In the literature, when YTS191 is used, several other antibodies or proteins are frequently employed alongside it to characterize immune subsets, controls, or as experimental comparators. Commonly used antibodies/proteins include:
These antibodies are often employed together in protocols such as:
The combination of these antibodies depends on the experimental design but CD8 and isotype controls are the most frequent companions of YTS191 in the literature. This is consistent across suppliers recommendations and published depletion protocols. Clone YTS191 is a widely used rat monoclonal antibody that specifically targets mouse CD4, a cell surface antigen found on thymocytes and helper/inducer T cells. The key findings from scientific literature regarding this clone include its application in cell identification, depletion, and immune modulation studies:
Additional details:
Summary Table:
No conflicting data were found in the cited literature; all sources agree on the key attributes and applications of the YTS191 clone. There is limited evidence concerning the detailed mechanistic effects of YTS191 beyond depletion, as most literature focuses on its use as a technical reagent for cell removal or detection. References & Citations1. Krijgsman D, et al. (2018) Front Immunol. 9:367 2. Esashi E, et al. (2003) J Immunol. 171(6):2773-7 3. Vremec D, et al. (2000) J Immunol. 164(6):2978-86 4. Li QJ, et al. (2004) Nat Immunol. 5:791–9 5. Janeway C. A. Jr. (1992) Annu Rev Immunol. 10:645–74 6. Germain RN. (2002) Nat Rev Immunol. 2(5):309-22 7. Thedrez A, et al. (2007) Blood. 110(1):251-8 8. Gibbings D & Befus AD. (2009) J Leukoc Biol. 86(2):251-9 Technical ProtocolsCertificate of Analysis |
Formats Available
